insulin degludec/insulin aspart 30

DRUG3 trials

Sponsors

Novo Nordisk A/S

Conditions

DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Healthy

Phase 1

Comparison of Explorative Formulation of Insulin Degludec and Insulin Aspart Co-formulation Versus Explorative Formulation of Insulin Degludec and Insulin Aspart Separately Compared With Biphasic Insulin Aspart 30 in Male Subjects With Diabetes

CompletedNCT01865305

Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2

Start: 2006-09-30End: 2007-02-28Updated: 2015-10-23

Safety, Pharmacokinetics and Pharmacodynamics of Two IDegAsp (One Explorative) Preparations and Two Insulin Degludec (One Explorative) Preparations in Japanese Subjects

CompletedNCT01868555

Novo Nordisk A/SDiabetes, Healthy

Start: 2007-12-31End: 2008-02-29Updated: 2015-10-22

Comparison of IDegAsp (Inclusive Three Explorative Formulations) With Insulin Degludec and Insulin Aspart Separately Injected in Subjects With Type 1 Diabetes

CompletedNCT01868568

Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 1

Start: 2008-04-30End: 2008-08-31Updated: 2015-10-22